Cannabis Is Betting Big on AI. The Operational Payoff Is Still Being Proven

How Cannabis Operators Can Turn Technology Investment Into Measurable Business Performance

Artificial intelligence is rapidly reshaping the cannabis sector, with multistate operators, licensed cultivators, dispensary networks, and ancillary technology vendors directing significant capital into tools designed to optimize seed-to-sale compliance, streamline cultivation and inventory management, and generate predictive insights across retail and supply chain operations. Yet despite this surge in investment, the financial return for many organizations remains difficult to quantify.

Data underscores the disconnect. McKinsey finds that while nearly nine in ten companies are investing in AI, only about four in ten can trace any measurable EBIT impact — and most of those gains account for less than five percent of profit, suggesting that a large share of today’s AI spending remains experimental rather than economically productive. Gartner has repeatedly warned that the majority of AI projects fail to deliver sustained business value without disciplined governance and operational integration. Leaders feel the tension. Investors demand capital efficiency. Boards ask harder questions. Where is the return. When does it show up. What risk have we introduced along the way.

Mamatha Chamarthi does not approach these questions as a theorist. She answers them as an operator who has delivered at scale. She scaled a $23 billion-dollar global software business across 14 brands at Stellantis. She led Elevate AI at Goodyear and drove 100 million dollars in measurable value within 90 days. Her track record is rooted in industrial systems, not innovation theater.

Transformation is not PowerPoint. It is operational. It is financial. It is behavioral, Chamarthi says. AI without cost savings is just another tech investment.

Her framing resonates because it speaks directly to the P&L. She argues that most AI programs fail before they…

Source